Labstyle Innovations Corp. announced that Erez Raphael, the President and Chief Executive Officer, was appointed to serve as a director on it's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | -5.93% |
|
-2.31% | -26.16% |
07-16 | DarioHealth Secures New Contract to Provide Cardiometabolic Solutions | MT |
07-16 | DarioHealth Corp. Expands GLP-1 Solution Client Base with New Employer Contract | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.16% | 40.4M | |
-4.90% | 179B | |
-1.36% | 100B | |
-7.64% | 46.16B | |
+12.00% | 44.81B | |
+9.63% | 44.38B | |
+13.63% | 29.53B | |
+20.01% | 25.83B | |
-7.12% | 23.97B | |
+4.03% | 22.5B |
- Stock Market
- Equities
- DRIO Stock
- News DarioHealth Corp.
- Labstyle Innovations Corp. Appoints Erez Raphael as Director on the Board of Directors